VETERINARY VACCINES MARKET ANALYSIS

Veterinary Vaccines Market, By Animal Type (Companion, Livestock), By Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, Subunit and DNA Vaccines, and Recombinant Vaccines), By Route of Administration (Subcutaneous Injection, Intramuscular Injection, Intranasal Administration, and Others), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Mar 2024
Code : CMI125
Pages :220
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges: High storage costs

High storage costs and complex production processes for vaccines are expected to hamper the growth of the veterinary vaccine market during the forecast period. For instance, proper vaccine storage and handling is an important factor in preventing and eradicating various common vaccine-preventable diseases. Each year failure of storage and handling errors results in revaccination of many patients and significant financial loss is experienced due to wasted vaccines. Moreover, failure to store and handle vaccines properly can reduce vaccine potency, resulting in inadequate immune responses in patients, and poor protection against diseases.

Market Opportunities: Emerging disease outbreaks

Rising pet ownership worldwide fuels the demand for companion animal vaccines. New technologies allow tailored vaccines for customized protection. Developing nations are promising markets as livestock vaccination increases. Contract vaccine manufacturing is a growing sector. Additionally, emerging disease outbreaks prompt urgent vaccine needs, allowing competitive advantages to those able to respond quickest.